BioSpace News Archive

Business

Statement - Minister Goodale welcomes the Office of the Correctional Investigator’s Annual Report

Today, the Honourable Ralph Goodale, Minister of Public Safety and Emergency Preparedness, issued the following statement in response of the Office of the Correctional Investigator’s (OCI) 2017-18 Annual Report.

October 30, 2018
·
1 min read
Business

Acceleron Reports Third Quarter 2018 Operating and Financial Results

Acceleron Pharma Inc. (Nasdaq:XLRN), a leading biopharmaceutical company in the discovery and development of TGF-beta therapeutics to treat serious and rare diseases, today provided a corporate update and reported financial results for the third quarter ended September 30, 2018.

October 30, 2018
·
9 min read
BioMidwest

Phillips-Medisize Connected Health Platform Now Available for Customized Connected Health Solutions

Phillips-Medisize, a Molex company, has completed the rollout of its innovative third-generation Connected Health Platform (CHP).

October 30, 2018
·
3 min read
Business

Vascular Insights® Announces New Chief Executive Officer and President James (Chip) Draper To Lead The Executive Team

Vascular Insights® is pleased to announce that James (Chip) Draper has been appointed Chief Executive Officer and President.

October 30, 2018
·
2 min read
Business

Nektar to Announce Financial Results for the Third Quarter 2018 on Wednesday, November 7, 2018, After Close of U.S.-Based Financial Markets

Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the third quarter on Wednesday, November 7, 2018,

October 30, 2018
·
1 min read
Business

Acerus to Report Third Quarter 2018 Financial Results and Host Investor Call

Acerus Pharmaceuticals Corporation (TSX:ASP) will announce its third quarter 2018 financial and operating results on Tuesday November 6, 2018 before market opens.

October 30, 2018
·
1 min read
Business

Well-Known Pet Care Executive Named CEO Of Animal Biosciences

Brought from Mars Petcare to Lead Animal Biosciences, One of Daughter Companies within Life Biosciences

October 30, 2018
·
2 min read
Drug Development

Actinium Pharmaceuticals CD33 Program to Focus on Actimab-MDS Pivotal Trial Enabling Study for Targeted Conditioning and Novel Combination Trials with Actimab-A and Venetoclax

Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) announced today that the next stage of development for its CD33 ARC (Antibody Radiation Conjugate) Ac-225-Lintuzumab program, after successful completion of the Actimab-A phase 2 trial in Acute Myeloid Leukemia (AML),

October 30, 2018
·
11 min read
Deals

Akebia Therapeutics Files Definitive Proxy Statement in Connection with Proposed Merger with Keryx Biopharmaceuticals

Akebia Therapeutics, Inc. (Nasdaq: AKBA) today announced that it and Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) filed a definitive joint proxy statement with the U.S. Securities and Exchange Commission (“SEC”)

October 30, 2018
·
17 min read
TSO3 Awarded Low Temperature Sterilization Contract pursuant to a Quebec Tender

TSO3 Inc. announced that the Company has been awarded a sole-source contract relating to a low temperature sterilizer Request for Proposal (or tender) in the Province of Quebec for its STERIZONE® VP4 Sterilizers.

October 30, 2018
·
4 min read